Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
HealthBeacon PLC - Dublin-based digital therapeutics company developing project for managing injectable medications - Says it will introduce its first US Green Labs facility in the United States in the fourth quarter this year.
The company says Green Labs is a positive step towards addressing the global challenge of sustainably managing patients' waste and supporting pharmaceutical companies to engage in more sustainable waste management practices. The company also announces the appointment of Omar Sosa as vice president of Global Operations and Green Labs USA.
HealthBeacon Chief Executive Officer Jim Joyce says: ‘Omar will support HealthBeacon's growth plans to bring our proven injection adherence technology to millions of US customers taking critical medications through injection in their homes. As we continue to grow, we are mindful of the impact we want to have as a business on the environment.
‘Ultimately, we want to improve injection adherence in a sustainable way and the introduction of our Green Labs facility in the United States is a key step in doing that.’
Current stock price: flat at €4.56
12-month change: down 23%
Copyright 2022 Alliance News Limited. All Rights Reserved.